Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Scusami who wrote (12875)	12/30/1997 2:02:00 PM
From: Arthur Radley	Read Replies (3) \| Respond to of 32384

Intersting segment on the local news(Houston) last night during their Health Beat report. Dealt with a promising drug that had performed well in shrinking tumors in testing in numerous trials. Further indicated that the future looked good for this new treatment but that in some cases the drug had not been effective. Spoke about the drug being in the retanoid category and therefore had few sideeffects. Didn't mention the drug by name but did show a vial with our favorite name....Ligand. With the M.D. Anderson Cancer Center here in Houston there is alot of attention given to drug testing in this TV report. Just maybe the good news is around the corner.